A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis

Gastroenterology

Volumn 112, Issue 3, 1997, Pages 718-724

  Hawkey, C J ^a   Dube, L M ^a   Rountree, L V ^a   Linnen, P J ^a   Lancaster, J F ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOXYGENASE INHIBITOR; MESALAZINE; STEROID; ZILEUTON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; ULCERATIVE COLITIS;

EID: 0031043010     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1997.v112.pm9041232     Document Type: Article

References (33)